Methylcobalamin is generally preferred for neuropathy, as it supports myelin sheath regeneration and direct nerve repair
BPC-157 may not be appropriate when: Imaging or specialist review has not yet been completed for a suspected structural injury There are acute red flag features (severe weakness, fever, rapid unexplained swelling, neurological changes, unexplained weight loss) The patient has active cancer or a history of certain cancers where angiogenic peptides require careful risk assessment The goal is rapid results without addressing underlying load, rehabilitation, or lifestyle drivers A peptide should not be used to delay evaluation that is clearly warranted
May 6, 2026 4 min read Anti-Aging Does MOTS-C Regulate AMPK Activity During Cellular Energy Stress
et al., Curr Med Chem (2012) Early claims of BPC-157s safety Jwiak M
PNPLA3-I148M: a problem of plenty in non-alcoholic fatty liver disease
Store reconstituted GHK-Cu at 2-8C (35-46F) constantly